Highly conserved influenza A virus epitope sequences as candidates of H3N2 flu vaccine targets

Genomics

Volumn 100, Issue 2, 2012, Pages 102-109

  Wu, Ko Wen ^a   Chien, Chih Yi ^a   Li, Shiao Wen ^a,b   King, Chwan Chuen ^c   Chang, Chuan Hsiung ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Bioinformatics; Broad spectrum vaccine; Epitope; Influenza virus

Indexed keywords

EPITOPE; INFLUENZA VACCINE; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; PROTEIN M1; PROTEIN M2; PROTEIN NA; PROTEIN NP; PROTEIN PA; PROTEIN PB1; PROTEIN PB1 F2; PROTEIN PB2; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DRUG TARGETING; GENE CLUSTER; GENETIC CONSERVATION; INFLUENZA A (H2N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H2N2; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SEQUENCE HOMOLOGY; VIRUS STRAIN; WILD TYPE;

CLUSTER ANALYSIS; EPITOPES; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; SEQUENCE ANALYSIS; VIRAL PROTEINS;

FLU VACCINE; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 84864071078     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2012.06.003     Document Type: Article

References (44)

1. Domingo E., Holland J.J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 1997, 51:151-178.
2. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., Fouchier R.A. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305:371-376.
3. Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007, 25:6852-6862.
4. Kilbourne E.D. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 2006, 12:9-14.
5. Fang R., Min Jou W., Huylebroeck D., Devos R., Fiers W. Complete structure of A/duck/Ukraine/63 influenza hemagglutinin gene: animal virus as progenitor of human H3 Hong Kong 1968 influenza hemagglutinin. Cell 1981, 25:315-323.
6. Scholtissek C., Rohde W., Von Hoyningen V., Rott R. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 1978, 87:13-20.
7. Taubenberger J.K., Hultin J.V., Morens D.M. Discovery and characterization of the 1918 pandemic influenza virus in historical context. Antivir. Ther. 2007, 12:581-591.
8. Heiny A.T., Miotto O., Srinivasan K.N., Khan A.M., Zhang G.L., Brusic V., Tan T.W., August J.T. Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLoS One 2007, 2:e1190.
9. Tan P.T., Heiny A.T., Miotto O., Salmon J., Marques E.T., Lemonnier F., August J.T. Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines. PLoS One 2010, 5:e8754.
10. Wang T.T., Tan G.S., Hai R., Pica N., Ngai L., Ekiert D.C., Wilson I.A., Garcia-Sastre A., Moran T.M., Palese P. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:18979-18984.
11. Neirynck S., Deroo T., Saelens X., Vanlandschoot P., Jou W.M., Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 1999, 5:1157-1163.
12. Corti D., Voss J., Gamblin S.J., Codoni G., Macagno A., Jarrossay D., Vachieri S.G., Pinna D., Minola A., Vanzetta F., Silacci C., Fernandez-Rodriguez B.M., Agatic G., Bianchi S., Giacchetto-Sasselli I., Calder L., Sallusto F., Collins P., Haire L.F., Temperton N., Langedijk J.P., Skehel J.J., Lanzavecchia A. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011, 333:850-856.
13. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., Santelli E., Stec B., Cadwell G., Ali M., Wan H., Murakami A., Yammanuru A., Han T., Cox N.J., Bankston L.A., Donis R.O., Liddington R.C., Marasco W.A. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 2009, 16:265-273.
14. ElHefnawi M., Alaidi O., Mohamed N., Kamar M., El-Azab I., Zada S., Siam R. Identification of novel conserved functional motifs across most influenza A viral strains. Virol. J. 2011, 8:44.
15. Gendoo D.M., El-Hefnawi M.M., Werner M., Siam R. Correlating novel variable and conserved motifs in the hemagglutinin protein with significant biological functions. Virol. J. 2008, 5:91.
16. Bush R.M., Fitch W.M., Bender C.A., Cox N.J. Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol. Biol. Evol. 1999, 16:1457-1465.
17. Bao Y., Bolotov P., Dernovoy D., Kiryutin B., Zaslavsky L., Tatusova T., Ostell J., Lipman D. The influenza virus resource at the National Center for Biotechnology Information. J. Virol. 2008, 82:596-601.
18. Ekiert D.C., Friesen R.H., Bhabha G., Kwaks T., Jongeneelen M., Yu W., Ophorst C., Cox F., Korse H.J., Brandenburg B., Vogels R., Brakenhoff J.P., Kompier R., Koldijk M.H., Cornelissen L.A., Poon L.L., Peiris M., Koudstaal W., Wilson I.A., Goudsmit J. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011, 333:843-850.
19. Chen J., Skehel J.J., Wiley D.C. N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:8967-8972.
20. Horvath A., Toth G.K., Gogolak P., Nagy Z., Kurucz I., Pecht I., Rajnavolgyi E. A hemagglutinin-based multipeptide construct elicits enhanced protective immune response in mice against influenza A virus infection. Immunol. Lett. 1998, 60:127-136.
21. Vareckova E., Mucha V., Wharton S.A., Kostolansky F. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies. Arch. Virol. 2003, 148:469-486.
22. Yano T., Nobusawa E., Nagy A., Nakajima S., Nakajima K. Effects of single-point amino acid substitutions on the structure and function neuraminidase proteins in influenza A virus. Microbiol. Immunol. 2008, 52:216-223.
23. Johansson B.E., Grajower B., Kilbourne E.D. Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice. Vaccine 1993, 11:1037-1039.
24. Epstein S.L., Kong W.P., Misplon J.A., Lo C.Y., Tumpey T.M., Xu L., Nabel G.J. Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Vaccine 2005, 23:5404-5410.
25. Ulmer J.B., Fu T.M., Deck R.R., Friedman A., Guan L., DeWitt C., Liu X., Wang S., Liu M.A., Donnelly J.J., Caulfield M.J. Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J. Virol. 1998, 72:5648-5653.
26. Patel A., Tran K., Gray M., Li Y., Ao Z., Yao X., Kobasa D., Kobinger G.P. Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses. Vaccine 2009, 27:3083-3089.
27. Das K., Aramini J.M., Ma L.C., Krug R.M., Arnold E. Structures of influenza A proteins and insights into antiviral drug targets. Nat. Struct. Mol. Biol. 2010, 17:530-538.
28. Assarsson E., Bui H.H., Sidney J., Zhang Q., Glenn J., Oseroff C., Mbawuike I.N., Alexander J., Newman M.J., Grey H., Sette A. Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J. Virol. 2008, 82:12241-12251.
29. Gerhard W., Mozdzanowska K., Furchner M., Washko G., Maiese K. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 1997, 159:95-103.
30. Webby R.J., Andreansky S., Stambas J., Rehg J.E., Webster R.G., Doherty P.C., Turner S.J. Protection and compensation in the influenza virus-specific CD8+ T cell response. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7235-7240.
31. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., Ewen C., Kane K.P., Bleackley R.C. T cell responses are better correlates of vaccine protection in the elderly. J. Immunol. 2006, 176:6333-6339.
32. Greenbaum J.A., Kotturi M.F., Kim Y., Oseroff C., Vaughan K., Salimi N., Vita R., Ponomarenko J., Scheuermann R.H., Sette A., Peters B. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20365-20370.
33. Tompkins S.M., Zhao Z.S., Lo C.Y., Misplon J.A., Liu T., Ye Z., Hogan R.J., Wu Z., Benton K.A., Tumpey T.M., Epstein S.L. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg. Infect. Dis. 2007, 13:426-435.
34. Rambaut A., Pybus O.G., Nelson M.I., Viboud C., Taubenberger J.K., Holmes E.C. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008, 453:615-619.
35. Creanza N., Schwarz J.S., Cohen J.E. Intraseasonal dynamics and dominant sequences in H3N2 influenza. PLoS One 2010, 5:e8544.
36. Stanekova Z., Vareckova E. Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development. Virol. J. 2010, 7:351.
37. Sette A., Newman M., Livingston B., McKinney D., Sidney J., Ishioka G., Tangri S., Alexander J., Fikes J., Chesnut R. Optimizing vaccine design for cellular processing, MHC binding and TCR recognition. Tissue Antigens 2002, 59:443-451.
38. Sidney J., Grey H.M., Kubo R.T., Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 1996, 17:261-266.
39. Gianfrani C., Oseroff C., Sidney J., Chesnut R.W., Sette A. Human memory CTL response specific for influenza A virus is broad and multispecific. Hum. Immunol. 2000, 61:438-452.
40. Bui H.H., Peters B., Assarsson E., Mbawuike I., Sette A. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:246-251.
41. Zhang Q., Wang P., Kim Y., Haste-Andersen P., Beaver J., Bourne P.E., Bui H.H., Buus S., Frankild S., Greenbaum J., Lund O., Lundegaard C., Nielsen M., Ponomarenko J., Sette A., Zhu Z., Peters B. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res. 2008, 36:W513-518.
42. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24:1596-1599.
43. Edgar R.C. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinforma. 2004, 5:113.
44. Mount D.W. Using the Basic Local Alignment Search Tool (BLAST). Cold Spring Harbor Protocols 2007, http://cshprotocols.cshlp.org/content/2007/7/pdb.top17.long. 10.1101/pdb.top17.